Victory Capital Management
NEOS

Victory Capital Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Victory Capital Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,368
Closed -$12K – 3638
2020
Q1 		$12K Buy
+16,368
New +$22.5K ﹤0.01% 3276
2019
Q4 		– Sell
-8,503
Closed -$13K – 3610
2019
Q3 		$13K Buy
+8,503
New +$13.8K ﹤0.01% 3187

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's NEOS Position: Q2 2020 in Review

Victory Capital Management sold out of Neos Therapeutics, Inc (NEOS) in Q2 2020, closing a stake of 16,368 shares — an estimated $12K sold.

Victory Capital Management first reported a position in NEOS in Q3 2019 and held it in 2 quarters. The position peaked at $13K in Q3 2019. 44 funds tracked by Wall St. Rank hold NEOS as of Q2 2020.

  • Victory Capital Management reported no remaining Neos Therapeutics, Inc position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 16,368 Neos Therapeutics, Inc shares in Q2 2020, an estimated $12K.
  • Victory Capital Management first reported a position in Neos Therapeutics, Inc in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Neos Therapeutics, Inc position peaked at $13K in Q3 2019.
  • 44 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.